GlassScriptPhysician profile
Kanwal K Nayyar
NPI 1043238371
$88,337.87
in general payments reported to CMS, 2019-2025
59 companies · $3,938 in 2025
The $3,938 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $17K · 2021: $9,831 · 2022: $16K · 2023: $12K · 2024: $6,679 · 2025: $3,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $10K · Consulting Fee: $413 · Travel and Lodging: $129 · Education: $41.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,565.00 |
| Food and Beverage | $10,411.77 |
| Consulting Fee | $413.00 |
| Travel and Lodging | $129.00 |
| Education | $41.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $71,457.24 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Ucb, INC. | $2,143.11 | 2019-2025 | Fintepla, Briviact, Zilbrysq |
| Abbvie INC. | $1,599.45 | 2021-2025 | |
| Sk Life Science, INC. | $1,138.56 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,027.19 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $1,019.52 | 2019-2025 | |
| Mdd US Operations, LLC | $780.87 | 2021-2025 | Gocovri, Apokyn, Apokyn |
| Genzyme Corporation | $643.83 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $550.30 | 2019-2025 | Nuplazid, Daybue |
| Sunovion Pharmaceuticals INC. | $502.70 | 2019-2022 | |
| Kyowa Kirin, INC. | $413.66 | 2019-2025 | Nourianz |
| Pfizer INC. | $406.35 | 2019-2025 | |
| Livanova USA, INC. | $406.11 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $377.00 | 2024-2025 | Valtoco |
| Supernus Pharmaceuticals, INC. | $376.61 | 2019-2021 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $376.25 | 2019-2024 | Emgality, Amyvid |
| Neurocrine Biosciences, INC. | $371.47 | 2021-2025 | Ingrezza, Ongentys |
| Greenwich Biosciences, INC. | $347.31 | 2019 | |
| Celgene Corporation | $337.33 | 2022-2025 | Zeposia |
| Eisai INC. | $312.34 | 2019-2025 | |
| Genentech USA, INC. | $260.20 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Astrazeneca Pharmaceuticals LP | $235.20 | 2022-2025 | Wainua |
| Ani Pharmaceuticals, INC. | $209.45 | 2024-2025 | Purified Cortrophin Gel |
| Janssen Pharmaceuticals, INC | $205.18 | 2021-2025 | Spravato |
| Sumitomo Pharma America, INC. | $198.48 | 2023-2024 | Aptiom |
| Amgen INC. | $196.70 | 2020-2025 | Uplizna |
| Otsuka America Pharmaceutical, INC. | $189.48 | 2024-2025 | Rexulti |
| Aucta Pharmaceuticals, INC. | $188.54 | 2024-2025 | Motpoly Xr |
| Emd Serono, INC. | $181.33 | 2019-2023 | Mavenclad |
| Lundbeck LLC | $169.04 | 2023-2025 | Vyepti, Rexulti |
| Amneal Pharmaceuticals LLC | $168.58 | 2019-2025 | Crexont, Rytary |
| Allergan, INC. | $131.39 | 2020 | |
| Scilex Pharmaceuticals INC. | $117.97 | 2022-2025 | Ztlido |
| Medtronic, INC. | $117.89 | 2024-2025 | Percept PC Brainsense |
| Argenx US, INC. | $111.15 | 2022-2023 | Vyvgart, Vyvgart Hytrulo |
| Avanir Pharmaceuticals, INC. | $83.58 | 2019-2021 | |
| Boston Scientific Corporation | $82.75 | 2021-2024 | |
| Springworks Therapeutics, INC. | $80.81 | 2025 | Gomekli |
| Merz Pharmaceuticals, LLC | $77.80 | 2024 | Xeomin |
| Medtronic USA, INC. | $69.93 | 2019 | |
| Horizon Therapeutics Plc | $56.74 | 2021 | |
| Cycle Pharmaceuticals INC | $55.13 | 2025 | Tascenso Odt, Bafiertam |
| Biohaven Pharmaceuticals, INC. | $54.88 | 2021 | |
| Adamas Pharmaceuticals, INC. | $53.52 | 2019-2021 | |
| Csl Behring | $52.66 | 2022 | |
| Abbott Laboratories | $50.02 | 2025 | Infinity |
| Acorda Therapeutics, INC | $43.47 | 2019 | |
| Upsher-Smith Laboratories LLC | $42.86 | 2019 | |
| Tanabe Pharma America, INC. | $38.15 | 2024 | |
| Tonix Medicines, INC. | $34.69 | 2025 | Tonmya |
| Takeda Pharmaceuticals U.S.A., INC. | $27.71 | 2025 | Hyqvia |
| Ge Healthcare | $26.30 | 2025 | |
| Forte Bio-Pharma LLC | $25.04 | 2025 | Tanlor |
| Vertical Pharmaceuticals, LLC | $23.50 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.86 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.23 | 2024 | Keveyis |
| Corium, LLC | $20.24 | 2023 | Adlarity |
| Arbor Pharmaceuticals, INC. | $13.27 | 2021 | |
| Collegium Pharmaceutical, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanwal Nayyar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.